Home
Screener
FATE
profile

FATE Company Profile and Key Details

NASDAQ : FATE

Fate Therapeutics, Inc.

$1.31

0.04+3.15%

At Close 4:00 PM

$1.33

0.02+1.53%

Pre-Market 07:45 PM

58.9

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

FATE Stock Price Chart

Stock Price Today

Fate Therapeutics, Inc. (FATE) stock surged +3.15%, trading at $1.31 on NASDAQ, up from the previous close of $1.27. The stock opened at $1.26, fluctuating between $1.23 and $1.31 in the recent session.

Stock Snapshot

1.27

Prev. Close

1.26

Open

149.2M

Market Cap

113.89M

Number of Shares

1.23

Day Low

1.31

Day High

-0.8

P/E Ratio

85.94%

Free Float in %

-1.64

EPS (TTM)

3.74

Book Value

-1.4

Cash Flow per Share

789.32K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2025	1.26	1.31	1.23	1.31	792.86K
Feb 03, 2025	1.27	1.30	1.21	1.27	1.24M
Jan 31, 2025	1.40	1.40	1.28	1.30	1.36M
Jan 30, 2025	1.33	1.41	1.31	1.37	1.13M
Jan 29, 2025	1.30	1.36	1.26	1.31	1.58M
Jan 28, 2025	1.37	1.38	1.28	1.30	1.09M
Jan 27, 2025	1.29	1.44	1.29	1.37	1.1M
Jan 24, 2025	1.32	1.35	1.29	1.33	1.07M
Jan 23, 2025	1.34	1.39	1.29	1.34	1.25M
Jan 22, 2025	1.33	1.37	1.28	1.34	2.46M
Jan 21, 2025	1.29	1.35	1.27	1.32	1.01M
Jan 17, 2025	1.28	1.30	1.24	1.27	1.27M
Jan 16, 2025	1.32	1.32	1.22	1.25	1.68M
Jan 15, 2025	1.31	1.36	1.26	1.32	2.11M
Jan 14, 2025	1.31	1.31	1.04	1.25	4.36M
Jan 13, 2025	1.45	1.45	1.28	1.29	6.3M
Jan 10, 2025	1.62	1.63	1.45	1.47	4.07M
Jan 08, 2025	1.73	1.75	1.63	1.67	1.69M
Jan 07, 2025	1.85	1.91	1.72	1.75	1.8M
Jan 06, 2025	1.85	1.99	1.78	1.87	2.86M

Contact Details

San Diego, CA 92131

United States

Website: https://www.fatetherapeutics.comContact: 858 875 1800

About Company

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current Fate Therapeutics, Inc. (FATE) stock price?

Fate Therapeutics, Inc. (NASDAQ: FATE) stock price is $1.31 in the last trading session. During the trading session, FATE stock reached the peak price of $1.31 while $1.23 was the lowest point it dropped to. The percentage change in FATE stock occurred in the recent session was 3.15% while the dollar amount for the price change in FATE stock was $0.04.

FATE's industry and sector of operation?

The NASDAQ listed FATE is part of Biotechnology industry that operates in the broader Healthcare sector. Fate Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FATE?

Dr. Bahram Valamehr Ph.D.
Chief R&D Officer
Ms. Cindy R. Tahl
Gen. Counsel & Corporation Sec.
Mr. Jim Beitel M.B.A.
Senior Vice President of Corporation Devel.
Mr. Edward J. Dulac III
Chief Financial Officer
Dr. Mark Plavsic D.V.M., Ph.D.
Chief Technical Officer
Dr. Sarah Cooley
Senior Vice President of Clinical Translation
Mr. Brian T. Powl M.B.A., M.S.
Chief Commercial Officer
Dr. Jerome Bressi Ph.D.
Senior Vice President of Regulatory & Quality
Mr. J. Scott Wolchko
Founder, Chief Executive Officer, Pres & Director
Dr. Yu-Waye Chu M.D.
Chief Medical Officer

How FATE did perform over past 52-week?

FATE's closing price is 25.96% higher than its 52-week low of $1.04 where as its distance from 52-week high of $8.83 is -85.16%.

How many employees does FATE have?

Number of FATE employees currently stands at 181.

Link for FATE official website?

Official Website of FATE is: https://www.fatetherapeutics.com

How do I contact FATE?

FATE could be contacted at phone 858 875 1800 and can also be accessed through its website. FATE operates from 12278 Scripps Summit Drive, San Diego, CA 92131, United States.

How many shares of FATE are traded daily?

FATE stock volume for the day was 789.32K shares. The average number of FATE shares traded daily for last 3 months was 3.24M.

What is the market cap of FATE currently?

The market value of FATE currently stands at $149.20M with its latest stock price at $1.31 and 113.89M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

FATE Stock Price Chart

Stock Price Today

Stock Snapshot

1.27

Prev. Close

1.26

Open

149.2M

Market Cap

113.89M

Number of Shares

1.23

Day Low

1.31

Day High

-0.8

P/E Ratio

85.94%

Free Float in %

-1.64

EPS (TTM)

3.74

Book Value

-1.4

Cash Flow per Share

789.32K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2025	1.26	1.31	1.23	1.31	792.86K
Feb 03, 2025	1.27	1.30	1.21	1.27	1.24M
Jan 31, 2025	1.40	1.40	1.28	1.30	1.36M
Jan 30, 2025	1.33	1.41	1.31	1.37	1.13M
Jan 29, 2025	1.30	1.36	1.26	1.31	1.58M
Jan 28, 2025	1.37	1.38	1.28	1.30	1.09M
Jan 27, 2025	1.29	1.44	1.29	1.37	1.1M
Jan 24, 2025	1.32	1.35	1.29	1.33	1.07M
Jan 23, 2025	1.34	1.39	1.29	1.34	1.25M
Jan 22, 2025	1.33	1.37	1.28	1.34	2.46M
Jan 21, 2025	1.29	1.35	1.27	1.32	1.01M
Jan 17, 2025	1.28	1.30	1.24	1.27	1.27M
Jan 16, 2025	1.32	1.32	1.22	1.25	1.68M
Jan 15, 2025	1.31	1.36	1.26	1.32	2.11M
Jan 14, 2025	1.31	1.31	1.04	1.25	4.36M
Jan 13, 2025	1.45	1.45	1.28	1.29	6.3M
Jan 10, 2025	1.62	1.63	1.45	1.47	4.07M
Jan 08, 2025	1.73	1.75	1.63	1.67	1.69M
Jan 07, 2025	1.85	1.91	1.72	1.75	1.8M
Jan 06, 2025	1.85	1.99	1.78	1.87	2.86M

Contact Details

San Diego, CA 92131

United States

Website: https://www.fatetherapeutics.comContact: 858 875 1800

About Company

Frequently Asked Questions

What is the current Fate Therapeutics, Inc. (FATE) stock price?

FATE's industry and sector of operation?

Who are the executives of FATE?

How FATE did perform over past 52-week?

FATE's closing price is 25.96% higher than its 52-week low of $1.04 where as its distance from 52-week high of $8.83 is -85.16%.

How many employees does FATE have?

Number of FATE employees currently stands at 181.

Link for FATE official website?

Official Website of FATE is: https://www.fatetherapeutics.com

How do I contact FATE?

FATE could be contacted at phone 858 875 1800 and can also be accessed through its website. FATE operates from 12278 Scripps Summit Drive, San Diego, CA 92131, United States.

How many shares of FATE are traded daily?

FATE stock volume for the day was 789.32K shares. The average number of FATE shares traded daily for last 3 months was 3.24M.

What is the market cap of FATE currently?

The market value of FATE currently stands at $149.20M with its latest stock price at $1.31 and 113.89M of its shares outstanding.

Employees	181
Beta	1.88
Sales or Revenue	$63.53M
5Y Sales Change%	6.654%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	181
Beta	1.88
Sales or Revenue	$63.53M
5Y Sales Change%	6.654%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

FATE Company Profile and Key Details

Fate Therapeutics, Inc.

FATE Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

FATE Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions